Our findings indicate that EMPA improves obesity-related kidney disease through reduction of NLRP3 inflammasome activity and upregulation of the HO-1–adiponectin axis, suggesting a novel mechanism for SGLT2i-mediated renal protection in obesity. The gene discussed is HMOX1; the disease is obesity due to melanocortin 4 receptor deficiency.